NCT00051454View on ClinicalTrials.gov

Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

February 28, 2005

Conditions
HIV Infections
Interventions
BIOLOGICAL

HIV DNA plasmid vaccine plus recombinant fowlpox vector

Trial Locations (1)

2010

National Centre in HIV Epidemiology and Clinical Research, Sydney

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00051454 - Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults | Biotech Hunter | Biotech Hunter